# US 8,278,267 B2 · Method of modifying food preference comprising administering amylin or amylin agonist

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,267 B2
- Document ID: US8278267B2
- Status: Granted
- Kind: B2
- Application number: 12/964,516
- Filed: 2010-12-09
- Published: 2011-10-27
- Granted: 2012-10-02
- Earliest claimed: 2005-03-31
- Assignees: Amylin Pharmaceuticals, Inc.
- Inventors: Christian Weyer; Kevin D. Laugero; Christine M. Mack; David G. Parkes
- Web page: https://patentgrep.com/patent/US8278267B2

## CPC

- A61K 38/22: Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K38/33, e.g. corticotropin A61K38/35)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/48: of the pancreatic hormones
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/20: Hypnotics; Sedatives
- A61P 25/22: Anxiolytics
- A61P 25/24: Antidepressants
- A61P 25/30: for treating abuse or dependence
- A61P 25/32: Alcohol-abuse
- A61P 25/34: Tobacco-abuse
- A61P 25/36: Opioid-abuse
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.

## Claims

### Claim 1

A method of modifying food preference of a subject desirous of modifying food preferences comprising administering to the subject an amylin or amylin agonist in an amount effective to modify the food preferences of the subject, wherein the amylin or amylin agonist is administered in an amount effective to decrease the subject's preference for high fat foods or for sweet foods.

### Claim 2 (depends on 1)

The method of claim 1, wherein the amylin or amylin agonist comprises the amino acid sequence of any one of SEQ ID NOS:3-253.

### Claim 3 (depends on 2)

The method of claim 2, wherein the amylin or amylin agonist is pramlintide (SEQ ID NO:6).

### Claim 4

A method of modifying food preference of a subject desirous of modifying food preferences comprising administering to the subject an amylin or amylin agonist in an amount effective to modify the food preferences of the subject, wherein the amylin or amylin agonist is administered in an amount effective to increase the subject's preference for low fat foods.

### Claim 5 (depends on 4)

The method of claim 4, wherein the amylin or amylin agonist comprises the amino acid sequence of any one of SEQ ID NOS:3-253.

### Claim 6 (depends on 5)

The method of claim 5, wherein the amylin or amylin agonist is pramlintide (SEQ ID NO:6).
